Qsymia (phentermine/topiramate)
Availability In clinic
What it is
Qsymia is a once-daily capsule combining two older drugs: phentermine, a stimulant appetite suppressant, and topiramate, an anti-seizure and migraine medicine that happens to blunt appetite. Approved in 2012 for chronic weight management, it was the leading prescription weight drug in the years before the GLP-1 class arrived and rearranged the category.
Why people take it
Cost and route. It is a pill rather than an injection, and it runs a fraction of what branded GLP-1 therapy costs, which matters when insurance declines to cover weight treatment at all. People also come to it after GLP-1 side effects they could not tolerate, or after a plateau, and medical weight programs still use it as a first-line or add-on option.
How it's delivered
Oral capsules taken each morning, stepped up over weeks through four fixed dose strengths. The phentermine makes it a controlled substance. It carries a risk management program because topiramate exposure in the first trimester raises the risk of cleft lip and palate, so pregnancy testing before starting and every month afterward is built into how it is prescribed.
Where the evidence stands
Well characterized, and clearly second tier now. In the registration trials, EQUIP and CONQUER, the top dose produced roughly 10 to 12 percent body weight loss over 56 weeks against a much smaller placebo effect, and an extension study held most of that through two years. That is near semaglutide territory and below tirzepatide, but the side effect profile differs in kind rather than degree: tingling in the hands and feet, dry mouth, insomnia, raised heart rate, mood changes, and word-finding difficulty from the topiramate. No trial has tested it for cardiovascular outcomes or for aging, and weight returns after stopping here as elsewhere.
Estimated cost
- $170–$250/mowithout insurance
- Far below brand-name GLP-1 pricing
- Prescription required; controlled substance
- Coverage for weight management varies widely
- Monthly pregnancy testing required for those who can conceive
Who offers it
- ClinicPrinceton Longevity Center weight program
- Clinicmedical weight-management programs
Observed in provider menus on our last research pass; each listing is stamped when verified. We may be compensated when you contact providers through Longevity.io; payment never affects ranking.
Go deeper
No Qsymia guide yet. Our GLP-1 guide covers the drug class that displaced it, which is the comparison most people are actually making.
Longevity.io is for educational purposes only and is not medical advice. Qsymia is contraindicated in pregnancy and in several common conditions, and whether it belongs in a plan is a conversation for a clinician who knows the whole picture. Confirm eligibility, services, and pricing directly with any provider.
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint
